Specification Sheet

Pos	No.	Sex	Age	Organ	Pathology diagnosis	Grade	Gleason Grade	Gleason Score	TNM	Type †
A1	1	M	43	Prostate	Normal prostatic tissue	–	–	–	–	Normal
A2	2	M	35	Prostate	Normal prostatic tissue	–	–	–	–	Normal
A3	3	M	28	Prostate	Normal prostatic tissue	–	–	–	–	Normal
A4	4	M	47	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A5	5	M	45	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A6	6	M	41	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A7	7	M	64	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A8	8	M	84	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A9	9	M	80	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
A10	10	M	77	Prostate	Cancer adjacent normal prostatic tissue	–	–	–	–	NAT
B1	11	M	66	Prostate	Adenocarcinoma (sparse)	1	1	1+1	T1NxM0	Malignant
B2	12	M	70	Prostate	Adenocarcinoma	2	3	3+3	T2aNxM0	Malignant
B3	13	M	66	Prostate	Adenocarcinoma	1	2	2+2	T3N1M1	Malignant
B4	14	M	61	Prostate	Adenocarcinoma	2	3	3+3	T2NxM0	Malignant
B5	15	M	64	Prostate	Adenocarcinoma	2	3	3+3	T3NxM1	Malignant
B6	16	M	75	Prostate	Adenocarcinoma (hyperplasia with prostatic intraepithelial neoplasia (PIN) grade I)	–	–	–	T3NxM1b	Malignant
B7	17	M	76	Prostate	Adenocarcinoma	1	2	1+2	TxNxMx	Malignant
B8	18	M	69	Prostate	Adenocarcinoma	2	3	3+3	T2NxM0	Malignant
B9	19	M	64	Prostate	Adenocarcinoma	3	5	5+4	T3NxM1b	Malignant
B10	20	M	69	Prostate	Adenocarcinoma	2–3	4	3+5	T2NxM0	Malignant
C1	21	M	56	Prostate	Adenocarcinoma	–	–	–	T2NxM0	Malignant
C2	22	M	70	Prostate	Adenocarcinoma	2	3	3+4	T2NxM0	Malignant
C3	23	M	78	Prostate	Adenocarcinoma	2	3	3+3	T4N1M1b	Malignant
C4	24	M	67	Prostate	Adenocarcinoma	1–2	2	2+3	T2NxM1	Malignant
C5	25	M	65	Prostate	Adenocarcinoma	2	3	3+3	T2NxM0	Malignant
C6	26	M	20	Prostate	Adenocarcinoma	2	3	3+3	T3N0M0	Malignant
C7	27	M	73	Prostate	Adenocarcinoma	2	3	3+3	T2NxM0	Malignant
C8	28	M	55	Prostate	Adenocarcinoma	1–2	2	2+2	T2NxM0	Malignant
C9	29	M	72	Prostate	Adenocarcinoma	3	4	4+5	T2NxM0	Malignant
C10	30	M	62	Prostate	Adenocarcinoma	2	3	3+4	T3N1M1b	Malignant
D1	31	M	70	Prostate	Adenocarcinoma (sparse)	3	5	5+5	T2NxM0	Malignant
D2	32	M	70	Prostate	Adenocarcinoma	2	3	2+3	TxN0M0	Malignant
D3	33	M	70	Prostate	Adenocarcinoma	2–3	4	5+3	T2NxM0	Malignant
D4	34	M	80	Prostate	Adenocarcinoma	2	3	3+4	T4N1M1c	Malignant
D5	35	M	69	Prostate	Adenocarcinoma (sparse)	–	–	–	T3NxM0	Malignant
D6	36	M	51	Prostate	Adenocarcinoma	2–3	3	3+5	T2N0M0	Malignant
D7	37	M	58	Prostate	Adenocarcinoma	2–3	4	4+3	T2NxM0	Malignant
D8	38	M	73	Prostate	Adenocarcinoma	3	5	5+4	T3N1M1c	Malignant
D9	39	M	73	Prostate	Adenocarcinoma (hyperplasia)	–	–	–	T3NxM1b	Malignant
D10	40	M	65	Prostate	Adenocarcinoma	3	4	4+5	T2N1M1	Malignant
E1	41	M	64	Prostate	Adenocarcinoma	3	5	4+5	T2NxM0	Malignant
E2	42	M	60	Prostate	Adenocarcinoma	2–3	3	3+4	T3N1M1b	Malignant
E3	43	M	70	Prostate	Adenocarcinoma	2–3	3	3+3	T3NxM0	Malignant
E4	44	M	73	Prostate	Adenocarcinoma	3	5	5+5	T4N1M1c	Malignant
E5	45	M	75	Prostate	Adenocarcinoma (chronic inflammation of prostate sparse)	–	–	–	T2N1M1c	Malignant
E6	46	M	69	Prostate	Adenocarcinoma (smooth muscle)	–	–	–	T1N0M0	Malignant
E7	47	M	82	Prostate	Adenocarcinoma	2–3	4	3+5	T2NxM0	Malignant
E8	48	M	76	Prostate	Adenocarcinoma	3	4	4+3	T3N1M1b	Malignant
E9	49	M	70	Prostate	Adenocarcinoma	3	4	4+3	T2N1M1c	Malignant
E10	50	M	40	Prostate	Adenocarcinoma	3	4	4+5	T2N1M1b	Malignant
F1	51	M	57	Prostate	Adenocarcinoma	2	2	2+4	T2aNxM0	Malignant
F2	52	M	73	Prostate	Adenocarcinoma	3	4	3+4	T3N1M1b	Malignant
F3	53	M	55	Prostate	Adenocarcinoma	3	4	4+5	T2NxM0	Malignant
F4	54	M	63	Prostate	Adenocarcinoma	3	4	4+4	T2N1M1b	Malignant
F5	55	M	72	Prostate	Adenocarcinoma	3	5	5+5	T3N0M0	Malignant
F6	56	M	60	Prostate	Adenocarcinoma	3	5	5+5	T2NxM0	Malignant
F7	57	M	87	Prostate	Adenocarcinoma	3	5	5+5	T2NxM0	Malignant
F8	58	M	75	Prostate	Adenocarcinoma	3	5	5+5	T3NxM0	Malignant
F9	59	M	57	Prostate	Adenocarcinoma	3	5	5+5	T4NxM0	Malignant
F10	60	M	82	Prostate	Adenocarcinoma	3	4	4+4	T2NxM0	Malignant
G1	61	M	62	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G2	62	M	78	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G3	63	M	73	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G4	64	M	64	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G5	65	M	70	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G6	66	M	73	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G7	67	M	74	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G8	68	M	81	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G9	69	M	72	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
G10	70	M	78	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H1	71	M	66	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H2	72	M	79	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H3	73	M	65	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H4	74	M	81	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H5	75	M	66	Prostate	Hyperplasia of prostate (sparse)	–	–	–	–	Hyperplasia
H6	76	M	67	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H7	77	M	72	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H8	78	M	56	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H9	79	M	76	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
H10	80	M	75	Prostate	Hyperplasia of prostate	–	–	–	–	Hyperplasia
–	–	M	58	Skin	Malignant melanoma (tissue marker)	–				Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis